July 9, 2026 3:54 PM
Novo Nordisk Launches Once-Weekly Basal Insulin Awiqli in India
Novo Nordisk India on Thursday announced the launch of Awiqli (insulin icodec), which the company says is the world's first once-weekly basal insulin for adults with Type 1 or Type 2 diabetes. The treatment reduces the insulin regimen from one injection every day to one injection every week, lowering the number of annual injections from 365 to 52. The company said Awiqli represents a major shift in insulin therapy by simplifying treatment rather than making incremental improvements. Ac...